Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 6Pancreatic Neoplasms 3Pancreatic Cyst 2Wilms Tumor 1Uveal Melanoma 1Thyroid Nodule 1Thyroid Diseases 1Prostatic Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Myasthenia Gravis 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia 1Intestinal Neuroendocrine Tumor 1Hyperthyroidism 1Hip Fractures 1Hematologic Neoplasms 1Goiter 1Glioma 1Glioblastoma 1Frailty 1Fractures, Spontaneous 1Financial Stress 1

Interventions

pembrolizumab 104Specimen Handling 55Magnetic Resonance Spectroscopy 48Biopsy 46Nivolumab 44Paclitaxel 35Gemcitabine 30Radiosurgery 29Carboplatin 28Ipilimumab 24Cyclophosphamide 22trastuzumab deruxtecan 21Irinotecan 21Cisplatin 21Capecitabine 20Leucovorin 19Pemetrexed 18Fulvestrant 18Fluorouracil 18130-nm albumin-bound paclitaxel 18Cetuximab 17Bevacizumab 17Taxes 16Oxaliplatin 16Drug Therapy 16Docetaxel 16olaparib 15abemaciclib 14Radiotherapy 14Trastuzumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Data Collection × 1 year × Clear all
NCT04387656 2026-05-27

NCI COVID-19 in Cancer Patients, NCCAPS Study

National Cancer Institute (NCI)

Active not recruiting
1,877 enrolled

COVID-19, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡